ConceptoMed today announce that it has entered into an exclusive distribution agreement with Mediplast AB.
Mediplast is a leading Nordic supplier of medical technical equipment and medical disposable products based in Sweden. Mediplast market and sell products from their own branded assortment of proprietary products combined with models from a select body of renowned suppliers.
Mediplast have gained exclusive right for the marketing, distribution and sale of the Luer-Jack syringe in Denmark, Finland and Sweden.
This distribution agreement builds upon ConceptoMed’s commitment to pursuing global distribution, and to offer an innovative addition to the traditional medical disposable syringe worldwide. ConceptoMed has, so far, announced distribution agreements for 14 countries in Europe and the Middle East, including the U.K.
The innovative Luer-Jack syringe is unique through the very simple one-hand operated disconnection function. Based on the leverage effect, the ‘Click and Release’ feature performs faster, safer and more efficient one-hand disconnections from needles and any other medical luer connections, and thereby reduces the risk of needlestick injuries. Using only one hand safeguards aseptic technique and could become a vital part of the on-going struggle to reduce the occurrence of hospital-acquired-infections.
‘Humans touch things. That’s the core contaminating problem related to blood borne hospital acquired infections and needlestick injuries. The greatness of Luer-Jack lies in its simplicity; large scale patient safety issues can be addressed with low-cost technology to enhance safety for both patients and healthcare workers’, says Christian Mide, M.D., CEO and founder of ConceptoMed.
‘Coming from Norway, it is truly exciting to partner with Mediplast from Sweden - such a recognized and well-esteemed medtech distributor. Mediplast is an ideal partner to address patient and healthcare safety issues in the Nordics’, says Mide.
‘Our relationship with ConceptoMed is a pivotal event for Mediplast, whose overall strategy is to further strengthen our market position within medtech products and medical disposables, both within proprietary and distribution products. Our products are designed to contribute to secure dependable healthcare for users and patients alike, and we achieve this by providing a targeted, evolving selection and working closely with our suppliers. Luer-Jack will accelerate our portfolio and help bring important new innovations to patients and healthcare professionals in the Nordics’, says Lars-Erik Rydell, Managing Director at Mediplast.
ConceptoMed AS is a rising medtech star serving the global market with innovative product categories and unique proprietary technology. We create smart medtech systems that empower healthcare professionals and improve patient care. Excellence through simplicity is our code. We are brave, curious and dedicated. We simply care.
Based in Norway, the team is continuously meeting milestones and expanding its activities for international growth. For more information on the company and career opportunities, see www.conceptomed.com and www.luerjack.com. Follow us on MyNewsdesk and LinkedIn.
Mediplast AB is a Swedish Group engaged in the sale and distribution of medical-technical products, primarily in the Nordic region. Our range consists of proprietary products combined with models from a select body of renowned suppliers, with whom we enjoy exclusive marketing partnerships. We also export proprietary products to the rest of the world. Our central storage facility in Malmö enables effective and speedy handling of shipments out to our customers.
Our range covers a broad spectrum, from disposable to non-disposable products and some highly technical advanced products.
In addition to marketing of our products, we provide our customers with the benefit of our unique expertise. We believe that "knowledge makes a difference", and put a premium on the proficiency and expertise of our workforce.
Luer-Jack® is a registered trademark owned by ConceptoMed AS. The Luer-Jack® technology is widely patent protected throughout the world, currently with almost 50 patents (granted and pending) from 8 patent families.
|For further information, please contact:||Jan Arne Jakobsen, CCO, ConceptoMed, +47 948 74 360 |
Christian Mide, CEO, ConceptoMed, +47 951 00 720
Lars-Erik Rydell, Managing Director, Mediplast, +46 709 464 877